Management for benign prostatic hyperplasia should include treatment of inflammation in prostate
The goal of management for benign prostatic hyperplasia (BPH) is to improve lower urinary tract symptoms (LUTS) of affected men. A recent article, Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia, World J Urology, 2020, concluded that “Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia”. This means that the treatment of BPH should take care of the inflammation that occurs along with the process of enlarging the prostate.
The only treatment method, which received a US patent – Dr Allen’s Device for Prostate Treatment, tackles both prostate enlargement and inflammation, also known as chronic prostatitis. The device treats the affected prostate gland by improving blood circulation in it. As a result, the use of the device reduces the enlarged or inflamed size of the prostate.
About a prostate gland
The prostate is a gland, which is a part of both the reproductive and urinary system. The prostate is, next to the seminal vesicales and the bulbourethral glands, part of the male accessory sex glands and produces seminal fluids which, during ejaculation, mix with sperm cells.
This mixture of fluid and sperm, known as semen, is what is moved through the urethra and out the penis during orgasm. In physiology this seminal fluids is needed to neutralize the acid vaginal milieu and nourish spermatozoa. .
Standard treatments of enlarged and inflamed prostate
In accordance with instructions urologists must prescribe to men with BPH drugs (different alpha-blockers or/and dutasteride – Avodart) and surgeries. They all may cause serious adverse events and complications, such as weakness, retrograde ejaculation, impotence, diabetes. As a result of these new problems, men become depressed, which significantly reduces their quality of life.
Contrary to conventional treatment options, Dr Allen’s therapeutic non-invasive device does not have side effects. It is Class I Medical Device without a measuring function and supplied in non-sterile condition does not require the involvement of a Notified Body. So it is permitted to use this device by everyone at home.
Dr Allen’s Device can be delivered worldwide
The 10-year use of Thermobalancing therapy with Dr Allen’s Device confirms its efficacy for prostate enlargement and inflamed prostate. 3-year clinical trials proved the effectiveness of Thermobalancing therapy and Dr Allen’s Device for enlarged and inflamed prostate.
The outcomes of this trial confirmed the fact that safe Dr Allen’s Device reduces the size of enlarged or inflamed prostate without medications and supplements. In accordance with the reduction in prostate size, men feel relief from LUTS, pain and other symptoms of chronic prostatitis.
Fine Treatment, delivers Dr Allen’s devices to all countries across the world. The delivery of Dr. Allen’s Device is guaranteed by Royal mail tracking service. Today, the devices have been successfully used by thousands customers in over 100 countries.
Erika White is a graduate of Parsons School of Design. Erika is based in Manhattan but travels much of the year. Erika has written for NPR, Motherboard, MSN Money, and the Huffington Post. Here at Morning News Ledger, Erika covers entertainment stories, focusing on performance arts and culture.